CN110132672A - A kind of histocyte fixating reagent and histocyte fixing means - Google Patents
A kind of histocyte fixating reagent and histocyte fixing means Download PDFInfo
- Publication number
- CN110132672A CN110132672A CN201910404527.3A CN201910404527A CN110132672A CN 110132672 A CN110132672 A CN 110132672A CN 201910404527 A CN201910404527 A CN 201910404527A CN 110132672 A CN110132672 A CN 110132672A
- Authority
- CN
- China
- Prior art keywords
- cell
- histocyte
- fixating reagent
- buffer solution
- fixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of histocyte fixating reagent and histocyte fixing means, the effective component of the cell fixating reagent is C16H28O4N3.The step of histocyte fixing means, is as follows: (1) appropriate PBS buffer solution being added, in culture medium for histiocyte;(2), configured cell fixating reagent as claimed in claim 2 is added in PBS buffer solution, the cell fixating reagent and the Volume fraction of PBS buffer solution are 1%-20%, it is 0.5-4 hours fixed, cell fixating reagent toxicity of the invention is low, non-volatility, it is preferable to histiocytic fixed effect, 6 months or more fixed effects can be maintained in PBS buffer solution.For fixing means provided by the invention compared with other cell fixation methods, outstanding advantages are that ionic liquid is non-volatile, are safe from harm to human body, in addition have easy to operate, it is at low cost, it is fixed after cell can long-term preservation in PBS aqueous solution, and cell fixed effect is preferable.
Description
Technical field
The present invention relates to a kind of histocyte fixating reagent and histocyte fixing means, belong to field of biotechnology.
Background technique
The type of histocyte fixative is more, and currently used cell fixative mainly has: aldehydes (common formaldehyde, penta
Dialdehyde and paraformaldehyde), alcohols (common ethyl alcohol), other (acetone).
Aldehydes:
Formaldehyde (formalin) is most widely used, principle: forming intermolecular crosslinking, influences protein configurations and be allowed to fixed.
Advantage: morphosis is kept, and penetrability is strong, and tissue contracts are few.Disadvantage: it is formic acid that formaldehyde, which is placed oxidable too long, is made molten
Liquid PH is reduced, and influences to dye;The amino of aldehyde radical and antigen protein is cross-linked to form carboxymethyl, goes out the three-dimensional conformation of antigenic determinant
Existing spatial obstacle;The network that intermolecular cross-linking is formed may partially or completely cover certain antigenic determinants, and being allowed to cannot
Sufficiently exposure.It can cause the coloration result of false negative.
Glutaraldehyde, penetrability is strong, and fine structure is kept, but fights original certain influence, often combines with other fixatives
As immuno-electron microscope fixer.
Paraformaldehyde (common 4%), can be used for immuno-electron microscope;It can also be used for immunofluorescence dyeing.It predominantly detects in tissue
The delicate antigen of some performances especially cell surface antigen, such as all kinds of lymphocytes break up determinant (CD), Main Tissues
Compatibility antigen etc..
Alcohols:
Most common alcohols fixative is ethyl alcohol.Its fixed function: precipitate intracellular protein, carbohydrate.Advantage: it wears
Permeability is strong, antigenicity is kept.Disadvantage: dehydration property is strong, and Yi Yinqi tissue contracts are hardened, and influences chipping qualities, thus ethyl alcohol is solid
Fix time unsuitable too long (in 2h).Ethyl alcohol keeps protein-denatured effect light, can be redissolved after fixed;In dyeing course, when incubation
Between it is long, antigen can be lost and weaken response intensity.
Other fixatives:
Acetone is kept to antigenic, but dehydration property is stronger, less to be used for tissue specimen, but cell climbing sheet common third
Ketone is fixed.
Above-mentioned cell fixer is all traditional volatile solvent, also there is certain harm to human body.
Summary of the invention
In order to overcome above-mentioned deficiency, the present invention provides a kind of new histocyte fixating reagents and histocyte fixation side
Method employs ionic liquids to replace traditional cell fixative.
Ionic liquid, usually also referred to as ionic liquid at room temperature, are DEG C salt being in a liquid state under room temperature or low temperature.It is generally by body
Relatively large, the asymmetric organic cation of product and the relatively small inorganic anion of volume are formed, due to zwitterion number
Mesh is equal, thus shows electroneutral on the whole.Ionic liquid has excellent physicochemical properties and can modify, the yin-yang of modulation
Ionic structure.Using ionic liquid as the solvent of reaction system or catalyst, since no vapour pressure, liquid temperature range are wide, point
It from being easy to carry out, has that homogeneous catalysis is high-efficient, the segregative advantage of heterogeneous catalysis concurrently, and can be recycled, receive in recent years
The extensive concern of each field scholar.
Technical scheme is as follows:
A kind of histocyte fixating reagent, the cell fixating reagent is a kind of ionic liquid, and effective component is
C16H28O4N3, chemical structural formula are as follows:
The cell fixative is C16H28O4N3With the mixed liquor of water.
C16H28O4N3Volume fraction with the mixed liquor of water is 1%-20%.Preferred volume score ratio is 10%.
A kind of histocyte fixing means, described steps are as follows:
(1), appropriate PBS buffer solution is added in culture medium for histiocyte;
(2), configured cell fixating reagent as claimed in claim 2 is added in PBS buffer solution, the cell is solid
The Volume fraction for determining reagent and PBS buffer solution is 1%-20%, preferably 10%;It is 0.5-4 hours, preferably 3 hours fixed.
Advantageous effects of the invention:
Ionic liquid provided by the invention have catalytic performance is high, easily separate with product, Yi Huishou, it is reusable, make
The advantages that with facilitating is the ideal substitute of traditional volatile solvent and catalyst, oneself is through becoming a kind of green material or Jie
Matter provides new opportunity for new " soft " functional material of materialized scholar development, while also finding a kind of green for chemist
Medium provide new thinking.
Moreover, ionic liquid toxicity of the invention is low, non-volatility is preferable to histiocytic fixed effect, PBS buffering
6 months or more fixed effects can be maintained in liquid.
For fixing means provided by the invention compared with other cell fixation methods, outstanding advantages are that ionic liquid is not waved
Hair, is safe from harm to human body, in addition have it is easy to operate, it is at low cost, it is fixed after cell can long-term preservation in PBS aqueous solution,
And cell fixed effect is preferable.
Detailed description of the invention
Fig. 1 is that mouse C2C12 cell initially fixes AO-EB colored graph after C2C12 cell;
Fig. 2 is the colored graph of AO-EB after mouse C2C12 cell is fixed 6 months;
Fig. 3 is the bright dark field plot one after mouse C2C12 cell is fixed 6 months;
Fig. 4 is the bright dark field plot two after mouse C2C12 cell is fixed 6 months.
Specific embodiment
The invention will be further described below in conjunction with the accompanying drawings.Following embodiment is only used for clearly illustrating the present invention
Technical solution, and not intended to limit the protection scope of the present invention.
A kind of histocyte fixating reagent, the cell fixating reagent is a kind of ionic liquid, and effective component is
C16H28O4N3, chemical structural formula are as follows:
The cell fixative is C16H28O4N3With the mixed liquor of water.
C16H28O4N3Volume fraction with the mixed liquor of water is 1%-20%.Preferred volume score ratio is 10%.
A kind of histocyte fixing means, described steps are as follows:
(1), appropriate PBS buffer solution is added in culture medium for histiocyte;
(2), configured cell fixating reagent as claimed in claim 2 is added in PBS buffer solution, the cell is solid
The Volume fraction for determining reagent and PBS buffer solution is 1%-20%;It is preferred that 10%;It is 0.5-4 hours, preferably 3 hours fixed.
Embodiment:
It chooses mouse cell (C2C12), culture medium therein is sucked out, add suitable PBS buffer solution, institute of the present invention is added
The ionic liquid stated makes the volume fraction 10% of PBS intermediate ion liquid, and the set time is 3 hours, and the colored graph of AO-EB is such as
Shown in Fig. 1.After fixation, the PBS buffer solution containing ionic liquid is sucked out, then cell 3-5 points after fixing are impregnated with PBS buffer solution
Clock, so far, cell is fixed to be completed, and can continue to dye in next step.It is illustrated in figure 2 AO-EB after C2C12 cell is fixed 6 months
Colored graph.Such as Fig. 3 and being illustrated in figure 4 the bright dark field plot after C2C12 cell is fixed 6 months.
From Fig. 3 and Fig. 4, we can observe that, after cell is fixed by ionic liquid, form is complete, and it is full, and not
It was found that the destruction of apparent cell appearance shrinkage and cell appearance.
We can observe that, karyomorphism is completely full from Fig. 2, and cytoplasm retains completely, and even dyeing.
It may be seen that cell fixed effect is relatively good from implementation, and the cell holding time is also longer.The above institute
Stating is only the preferred embodiment of the present invention, it is noted that for those skilled in the art, is not being departed from
Under the premise of the technology of the present invention principle, several improvement and deformations can also be made, these improvement and deformations also should be regarded as the present invention
Protection scope.
Claims (7)
1. a kind of histocyte fixating reagent, which is characterized in that the effective component of the cell fixating reagent is C16H28O4N3, change
Learn structural formula are as follows:
2. a kind of histocyte fixating reagent as described in claim 1, it is characterised in that: the cell fixative is
C16H28O4N3With the mixed liquor of water.
3. a kind of histocyte fixating reagent as claimed in claim 2, it is characterised in that: the C16H28O4N3With the mixing of water
The volume ratio of liquid is 1%-20%.
4. a kind of histocyte fixating reagent as claimed in claim 3, it is characterised in that: the C16H28O4N3With mixing for pure water
The preferred volume score ratio for closing liquid is 10%.
5. a kind of histocyte fixing means, it is characterised in that described steps are as follows:
(1), appropriate PBS buffer solution is added in culture medium for histiocyte;
(2), configured cell fixating reagent as claimed in claim 2 is added in PBS buffer solution, the fixed examination of the cell
The Volume fraction of agent and PBS buffer solution is 1%-20%;It is 0.5-4 hours fixed.
6. a kind of histocyte fixing means as claimed in claim 5, it is characterised in that the fixed examination of cell in the step (2)
The preferred volume score ratio of agent and PBS buffer solution is 10%.
7. a kind of histocyte fixing means as claimed in claim 5, it is characterised in that when cell is fixed in the step (2)
Between preferably 3 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910404527.3A CN110132672B (en) | 2019-05-16 | 2019-05-16 | Tissue cell fixing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910404527.3A CN110132672B (en) | 2019-05-16 | 2019-05-16 | Tissue cell fixing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110132672A true CN110132672A (en) | 2019-08-16 |
CN110132672B CN110132672B (en) | 2021-12-03 |
Family
ID=67574140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910404527.3A Active CN110132672B (en) | 2019-05-16 | 2019-05-16 | Tissue cell fixing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110132672B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019931A (en) * | 2019-12-19 | 2020-04-17 | 苏州浚惠生物科技有限公司 | Exfoliated cell fixing method for single cell amplification |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586695A (en) * | 2004-08-05 | 2005-03-02 | 中国科学院过程工程研究所 | Novel pH value self adjustable ionic liquid double water phase |
CN101033213A (en) * | 2007-03-30 | 2007-09-12 | 辽宁大学 | Phenylalanine-1-methyl-3-butyl-imidazole amino acid ionic liquid and preparing method thereof |
CN101084746A (en) * | 2007-07-12 | 2007-12-12 | 江苏省原子医学研究所 | Specimen anti-corrosion stationary liquid |
CN101891685A (en) * | 2010-07-16 | 2010-11-24 | 齐齐哈尔大学 | Alkyl imidazole-L-proline salt chiral ionic liquid and preparation method thereof |
CN102010371A (en) * | 2010-10-27 | 2011-04-13 | 华南理工大学 | Proline ionic liquid and preparation method and application thereof |
CN102633724A (en) * | 2011-02-14 | 2012-08-15 | 同济大学 | Amino acid imidazolium ionic liquid and preparation method thereof |
CN103046055A (en) * | 2013-01-15 | 2013-04-17 | 四川理工学院 | Imidazolyl lysine salt ionic liquid steel corrosion inhibitor and application thereof |
CN104853738A (en) * | 2012-12-20 | 2015-08-19 | 高露洁-棕榄公司 | Oral care composition containing ionic liquids |
CN108949738A (en) * | 2018-07-25 | 2018-12-07 | 嘉兴学院 | A kind of preparation method and applications of the microsphere immobilized cell of magnetic loading ionic liquid |
-
2019
- 2019-05-16 CN CN201910404527.3A patent/CN110132672B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586695A (en) * | 2004-08-05 | 2005-03-02 | 中国科学院过程工程研究所 | Novel pH value self adjustable ionic liquid double water phase |
CN101033213A (en) * | 2007-03-30 | 2007-09-12 | 辽宁大学 | Phenylalanine-1-methyl-3-butyl-imidazole amino acid ionic liquid and preparing method thereof |
CN101084746A (en) * | 2007-07-12 | 2007-12-12 | 江苏省原子医学研究所 | Specimen anti-corrosion stationary liquid |
CN101891685A (en) * | 2010-07-16 | 2010-11-24 | 齐齐哈尔大学 | Alkyl imidazole-L-proline salt chiral ionic liquid and preparation method thereof |
CN102010371A (en) * | 2010-10-27 | 2011-04-13 | 华南理工大学 | Proline ionic liquid and preparation method and application thereof |
CN102633724A (en) * | 2011-02-14 | 2012-08-15 | 同济大学 | Amino acid imidazolium ionic liquid and preparation method thereof |
CN104853738A (en) * | 2012-12-20 | 2015-08-19 | 高露洁-棕榄公司 | Oral care composition containing ionic liquids |
CN103046055A (en) * | 2013-01-15 | 2013-04-17 | 四川理工学院 | Imidazolyl lysine salt ionic liquid steel corrosion inhibitor and application thereof |
CN108949738A (en) * | 2018-07-25 | 2018-12-07 | 嘉兴学院 | A kind of preparation method and applications of the microsphere immobilized cell of magnetic loading ionic liquid |
Non-Patent Citations (3)
Title |
---|
PRZEMYSLAW MAJEWSKI ET AL.: "Ionic liquids in embalming and tissue preservation.Can traditional formalin-fixation be replaced safely?", 《ACTA HISTOCHEMICA》 * |
周雪媚 等: "遗体(尸体)防腐剂研究现状", 《解剖科学进展》 * |
陆进 等: "离子保存液对标本防霉效果的观察分析", 《山西医科大学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019931A (en) * | 2019-12-19 | 2020-04-17 | 苏州浚惠生物科技有限公司 | Exfoliated cell fixing method for single cell amplification |
Also Published As
Publication number | Publication date |
---|---|
CN110132672B (en) | 2021-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5196182A (en) | Tissue fixative | |
Kellenberger | The potential of cryofixation and freeze substitution: observations and theoretical considerations | |
Sung et al. | Stability of a biological tissue fixed with a naturally occurring crosslinking agent (genipin) | |
Ris et al. | The state of the chromosomes in the interphase nucleus | |
Roth | Post‐embedding cytochemistry with gold‐labelled reagents: a review | |
Locke et al. | Hot alcoholic phosphotungstic acid and uranyl acetate as routine stains for thick and thin sections | |
Peters Jr et al. | An artefact in radioautography due to binding of free amino acids to tissues by fixatives | |
de Martino et al. | Silver methenamine stain for electron microscopy | |
JP2010509593A (en) | Biopolymer sensor and manufacturing method thereof | |
JPS58206965A (en) | Conserving agent for biological system and fixative compounding | |
CN110132672A (en) | A kind of histocyte fixating reagent and histocyte fixing means | |
BR112013028298B1 (en) | production of a fixative solution for fixing and preserving biological samples | |
US4490461A (en) | Process for the preparation of photographic materials | |
Katikireddy et al. | Immunohistochemical and immunofluorescence procedures for protein analysis | |
Frösch et al. | Melamine resins and their application in electron microscopy | |
CN105021431A (en) | Resin embedding method for biological tissues marked by fluorescent protein and application of alkaline solution | |
Kakefuda et al. | Electron microscopic observations on the ribonucleic acid of murine leukemia virus | |
Boyde et al. | Scanning electron microscopic observations of chick embryo fibroblasts in vitro, with particular reference to the movement of cells under others | |
US20100099140A1 (en) | Methods and compositions for preventing artifacts in tissue samples | |
CN108106909B (en) | Biological tissue light transparentizing agent, light transparentizing method and application thereof | |
Carnegie et al. | Embedment in glycol methacrylate at low temperature allows immunofluorescent localization of a labile tissue protein. | |
Proctor Jr | Penetration of the walls of wood cells by the hyphae of wood-destroying fungi | |
Gibbons | Reactivation of sperm flagella: properties of microtubule-mediated motility | |
Hand | Plastic embedding for light microscopy | |
US4201693A (en) | Stable schiff reagent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |